ARTICLE | Company News
Aventis vaccine deal with FibroGen
January 18, 2001 8:00 AM UTC
Aventis (AVE) vaccine division Aventis Pasteur and FibroGen (South San Francisco, Calif.) will develop synthetic gelatins in yeast for use as stabilizers in vaccines. Denatured collagen (gelatin) is c...